Portefeuille d'ETF CANC (NASDAQ) - Page 3 | MetaTrader

Afficher le graphique complet Full chart

Aperçu Toutes les participations Heatmap

Principaux titres en portefeuille Market Value Shares Weight %

T

TERN Terns Pharmaceuticals Inc 1.2 M 28.0 K 0.7%

First American Treasury Obliga 1.0 M 1.0 M 0.6%

XNCR Xencor Inc 982.4 K 76.9 K 0.6%

TYRA Tyra Biosciences Inc 947.3 K 28.4 K 0.6%

GH Guardant Health Inc 939.8 K 10.0 K 0.6%

RCUS Arcus Biosciences Inc 936.1 K 46.0 K 0.6%

AVBP ArriVent Biopharma Inc 935.9 K 40.7 K 0.6%

IMCR Immunocore Holdings PLC 913.3 K 28.3 K 0.6%

HCM HUTCHMED China Ltd 890.3 K 62.1 K 0.6%

GLUE Monte Rosa Therapeutics Inc 808.1 K 45.5 K 0.5%

CGEM Cullinan Therapeutics Inc 729.5 K 47.1 K 0.5%

CMPX Compass Therapeutics Inc 720.2 K 127.5 K 0.5%

JANX Janux Therapeutics Inc 642.3 K 47.2 K 0.4%

NTRA Natera Inc 634.3 K 3 049.0 0.4%

ARVN Arvinas Inc 601.5 K 45.3 K 0.4%

ORIC ORIC Pharmaceuticals Inc 476.2 K 35.4 K 0.3%

1
2
3

Nouvelles

Les actions de Cogent Biosciences grimpent après l'acceptation par la FDA de la demande d'approbation de médicament clé | Benzinga France

GNOM, CANC, IBB: Use Targeted Healthcare ETFs to Build Wealth - TipRanks.com

Here's Why Biotech ETFs Are Rallying Hard

Be Thankful to These ETFs This Year

Inside the Recent Strength in Biotech ETFs

Biotech ETFs Bounce Back in 2025: Here's Why